2025 ADVENT Forum | Latest Clinical Data from the COPD Biologic Treatment Landscape

• Explore the specific mechanisms of action of current and pipeline biologic agents, understanding how they target underlying inflammatory pathways in COPD
• Learn about the evolving criteria for identifying appropriate patient populations who stand to benefit most from biologic interventions

In a time where precision medicine is transforming chronic disease management, the role of biologics in COPD is rapidly evolving. This comprehensive video presentation cuts through the complexity, delivering clear, concise, and critical insights directly from the experts at the forefront of research and patient care.

Featuring an unparalleled panel of global leaders in respiratory medicine – Professor Klaus Rabe, MD, PhD,  Professor Claus Vogelmeier, MD, and Professor Wisia Wedzicha, MD – this session offers an exclusive look at the most recent and impactful clinical data shaping the biologic landscape for COPD disease management.